|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_on1242406246 |
| 003 |
OCoLC |
| 005 |
20231120010536.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
210319s2021 enk o 000 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d OPELS
|d OCLCO
|d EBLCP
|d OCLCF
|d OCLCQ
|d OCLCO
|d COM
|d N$T
|d SFB
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9780128217009
|q (electronic bk.)
|
| 020 |
|
|
|a 0128217006
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128217122
|
| 035 |
|
|
|a (OCoLC)1242406246
|
| 050 |
|
4 |
|a RC270.8
|
| 082 |
0 |
4 |
|a 616.994
|2 23
|
| 245 |
0 |
0 |
|a Multifunctional theranostic nanomedicines in cancer /
|c edited by Malay K. Das.
|
| 260 |
|
|
|a London :
|b Academic Press,
|c 2021.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Front Cover -- Multifunctional Theranostic Nanomedicines in Cancer -- Copyright Page -- Contents -- List of contributors -- 1 Nanoparticle-based theranostics in cancer -- 1.1 Introduction -- 1.2 Fundamental of nanotheranostics for diagnosis and therapy -- 1.3 Nanoparticles in the treatment of cancer theranostics -- 1.3.1 Organic nanoparticles -- 1.3.1.1 Liposomes -- 1.3.1.2 Solid lipid nanoparticles -- 1.3.1.3 Polymeric dendrimers -- 1.3.1.4 Polymeric micelles -- 1.3.1.5 Polymer-drug conjugate -- 1.3.2 Inorganic nanoparticles -- 1.3.2.1 Iron oxide nanoparticles -- 1.3.2.2 Gold nanoparticles
|
| 505 |
8 |
|
|a 1.3.2.3 Silica nanoparticles -- 1.3.2.4 Gadolinium nanoparticles -- 1.3.2.5 Carbon nanotubes -- 1.3.2.6 Quantum dots -- 1.4 Imaging guidance used in nanotheranostics -- 1.4.1 Optical imaging -- 1.4.2 Magnetic resonance imaging -- 1.4.3 Computed tomography -- 1.4.4 Positron emission tomography (PET) -- 1.4.5 Single-photon emission computed tomography (SPECT) -- 1.4.6 Ultrasonic imaging -- 1.5 Role of nanotheranostics in cancer treatment -- 1.5.1 Strategies of nanotheranostics for cancer treatment -- 1.5.1.1 Passive targeting -- 1.5.1.2 Active targeting -- 1.5.1.3 Stimuli-responsive targeting
|
| 505 |
8 |
|
|a 1.5.1.3.1 pH as stimuli -- 1.5.1.3.2 Redox reactions -- 1.5.1.3.3 Hypoxia -- 1.5.1.3.4 Enzyme-responsive nanotheranostic agent -- 1.5.1.3.5 Temperature-stimulated nanotheranostics -- 1.5.1.3.6 Photo/light-triggered nanotheranostics -- 1.5.1.3.7 Magnetic field-triggered nanotheranostics -- 1.5.1.3.8 Ultrasound-triggered nanotheranostics -- 1.6 Clinical application of nanotheranostics -- 1.7 Conclusion and future perspective -- Conflict of interest -- References -- 2 Multifunctional nanotheranostics for cancer diagnosis and treatments -- 2.1 Introduction -- 2.2 Imaging modalities
|
| 505 |
8 |
|
|a 2.2.1 Optical imaging -- 2.2.1.1 NIRF imaging -- 2.2.1.2 Surface enhanced Raman spectroscopy imaging -- 2.2.2 Magnetic resonance imaging -- 2.2.2.1 Gd-based nanoparticles -- 2.2.2.2 Iron oxide contrast agent -- 2.2.3 Nuclear (radionuclide based) imaging -- 2.2.3.1 Single photo emission computed tomography -- 2.2.3.2 Positron emission tomography -- 2.2.4 Ultrasound-based imaging -- 2.3 Different multifunctional nanocarriers used as theranostic system -- 2.3.1 Polymer conjugates -- 2.3.2 Dendrimers -- 2.3.3 Polymeric micelles -- 2.3.4 Superparamagnetic iron oxide nanoparticles -- 2.3.5 Quantum dots
|
| 505 |
8 |
|
|a 2.3.6 Carbon dots (graphene quantum dots) -- 2.3.7 Gold nanostructures -- 2.3.8 Stimuli responsive -- 2.3.8.1 Temperature sensitive -- 2.3.8.2 pH sensitive -- 2.3.8.3 Ultrasound responsive -- 2.4 Conclusions -- Acknowledgment -- Conflict of interest -- References -- 3 Multifunctional micellar nanomedicine for cancer therapy -- 3.1 Introduction -- 3.2 Polymeric micelles -- 3.2.1 Structure and composition of micelles -- 3.2.2 Advantage of polymeric micelles -- 3.3 Advanced functions of micellar nanomedicine -- 3.3.1 Active targeting -- 3.3.2 Passive targeting
|
| 650 |
|
0 |
|a Cancer
|x Treatment.
|
| 650 |
|
0 |
|a Cancer
|x Imaging.
|
| 650 |
|
0 |
|a Nanomedicine.
|
| 650 |
|
2 |
|a Nanomedicine
|0 (DNLM)D050997
|
| 650 |
|
6 |
|a Cancer
|x Traitement.
|0 (CaQQLa)201-0004693
|
| 650 |
|
6 |
|a Cancer
|x Imagerie.
|0 (CaQQLa)201-0205441
|
| 650 |
|
6 |
|a Nanom�edecine.
|0 (CaQQLa)201-0448752
|
| 650 |
|
7 |
|a Cancer
|x Imaging
|2 fast
|0 (OCoLC)fst00845381
|
| 650 |
|
7 |
|a Cancer
|x Treatment
|2 fast
|0 (OCoLC)fst00845538
|
| 650 |
|
7 |
|a Nanomedicine
|2 fast
|0 (OCoLC)fst01744350
|
| 700 |
1 |
|
|a Das, Malay K.
|
| 776 |
0 |
8 |
|i Print version:
|t Multifunctional theranostic nanomedicines in cancer.
|d London : Academic Press, 2021
|z 012821712X
|z 9780128217122
|w (OCoLC)1195449731
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128217122
|z Texto completo
|
